FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088287 [Registered on: 05/06/2025] Trial Registered Prospectively
Last Modified On: 04/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Mole removal with the help of shankadrava liquid. 
Scientific Title of Study   A single arm clinical study to evaluate the efficacy of Shankhadrava application for removal of Mashaka to avoid its recurrence w.s.r. to mole. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL   NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Hrishikesh Vishnu Kolhe 
Designation  MS Scholar Shalyatantra Samanya Department  
Affiliation  Department of Shalyatantra Samanya, Shree Saptashrungi Ayurved Mahavidyalaya,Nashik 
Address  Department of Shalyatantra Samanya, Shree Saptashrungi Ayurved Mahavidyalaya,Kamal nagar, Hiravadi, Panchavati, Nashik, Maharashtra 422003 India

Nashik
MAHARASHTRA
422003
India 
Phone  7775810624  
Fax    
Email  hrishkolhe2017@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Aparna Raut 
Designation  H.O.D. Shalyatantra Department  
Affiliation  Department of Shalyatantra Samanya,Shree Saptashrungi Ayurved Mahavidyalaya,Nashik 
Address  Department of Shalyatantra Samanya,Shree Saptashrungi Ayurved Mahavidyalaya,Kamal nagar Hiravadi, Panchavati, Nashik, Maharashtra 422003 India

Nashik
MAHARASHTRA
422003
India 
Phone  9822979769  
Fax    
Email  dr.aparnaraut12@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Hrishikesh Vishnu Kolhe  
Designation  M.S. Scholar Shalyatantra Samanya Department 
Affiliation  Shree Saptashrungi Ayurved Mahavidyalaya 
Address  Department of Shalyatantra Samanya, Shree Saptashrungi Ayurved Mahavidyalaya,Kamal nagar Hiravadi, Panchavati, Nashik, Maharashtra 420003 India

Nashik
MAHARASHTRA
422003
India 
Phone  7775810624  
Fax    
Email  hrishkolhe2017@gmail.com  
 
Source of Monetary or Material Support  
Shalyatanta department,OPD no. 1,Shree Saptashrungi Ayurved Mahavidyalaya And Hospital , KamalNagar , Hirawadi , Panchwati, Nashik Maharashtra 422003 
 
Primary Sponsor  
Name  Department of Shalyatantra Shree Saptashrungi Ayurved Mahavidyalaya 
Address  Department of Shalyatantra Samanya, Shree Saptashrungi Ayurved Mahavidyalaya,Kamal nagar Hiravadi, Panchavati, Nashik, Maharashtra 422003 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Hrishikesh Vishnu Kolhe   Department Of Shalyatanta,Shree Saptashrungi Ayurved Mahavidyalaya And Hospital  Department Of Shalyatanta,OPD no. 1,Shree Saptashrungi Ayurved Mahavidyalaya And Hospital, Kamal Nagar , Hirawadi , Panchawati , Nashik 422003 Nashik MAHARASHTRA
Nashik
MAHARASHTRA 
7775810624

hrishkolhe2017@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Shree Saptashrungi Ayurved Mahavidyalaya Nashik Panchavati Nashik Maharashtra 422003  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L918||Other hypertrophic disorders of the skin. Ayurveda Condition: MASHAKAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Shankhadrava , Reference: Rasatarangini Dwadashtarang 35-39, Route: Topical, Dosage Form: Arka, Dose: 0.5(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Weeks, anupAna/sahapAna: No, Additional Information: Topical application of shakharava arka 2 times a day over mole site only
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  a)Individuals of mashaka(mole) having hard, painless, black and Elevated eruption on the body (skin) resembling the masha (pulse) in shape.
b)Sites:-face (except eyelids),legs, back,chest,neck,groin region
c)Patients in the age group of 18 to 40 years.
d)Patients will be selected irrespective of sex, religion, socio – economic status etc.  
 
ExclusionCriteria 
Details  1)The patient age group is less than 18 and more than 40 years.(Baal,vruddha,Durbal,pregnant women also) 2)Tilkalaka of shuk roga. 3)Patient suffering from any other skin disorders like psoriasis, dermatitis, vitiligo, melasma, malignant melanoma and acne.
4) Patient having chronic infectious diseases like Koch’s, leprosy, Hypersensitivity, cancer and diabetes. 5)Contraindicated to Shankhadrava application
Raktapitta (bleeding disorders) ,Timira (eye disease), Moorchha (unconscious), Sira (head), Snayu (tendons), Sandhi (joints), Tarunasthi (ligament bones), Dhamani.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
effect of shankhadrava drops application in mashaka removal from its base and to check its recurrence.   21 days 
 
Secondary Outcome  
Outcome  TimePoints 
Adverse effect of Shankhadrava application.
mole characteristics from modern perspective. 
30 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   16/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a Phase I/II single-arm clinical trial aimed at evaluating the efficacy and safety of Shankhadrava, an Ayurvedic preparation, in the management of Mashaka (moles). The study will assess the potential of Shankhadrava to remove moles from their base and prevent recurrence through its cauterizing and detoxifying properties. A total of 40 eligible participants, aged 18–40 years, presenting with Mashaka will receive topical application of Shankhadrava for a maximum of 21 days. The trial will monitor changes in mole characteristics (size, color, elevation, texture), recurrence, and any adverse effects. The findings may provide a natural, cost-effective alternative to modern mole removal techniques. 
Close